By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – San Francisco molecular diagnostics firm MLC Dx has raised almost $6 million in a private financing, it disclosed in a document filed with the US Securities and Exchange Commission this week.

The amount raised is part of an offering that seeks to raise a total of $9.7 million, according to the company's filing, which also stated that the offering comprised of equity, options, warrants, and other rights to acquire another security.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.